">
Hadassah

Prioritizing Treatment Options in Breast Cancer

Tuesday, Jul 3 2018

When a patient with metastatic breast cancer fails to respond to conventional treatment and gene analysis identifies several targetable molecular mutations, how do you prioritize treatment options?

Hadassah Medical Center oncologists, together with Weizmann Institute of Science and Hebrew University colleagues, dealt with this dilemma of prioritizing treatment through an ex-vivo organ culture (EVOC) system. Having found several mutations of the tumor, doctors treated the tumor outside the body (EVOC) with several agents recommended for that particular mutation profile. The tumor response to those agents was then analyzed. Later, the patient herself received the treatment that showed the best tumor shrinkage in the EVOC.

The authors, whose article on the subject appears in the April 13, 2018, issue of Cancer Biology and Therapy, note that their findings “provide a potential rationale for utilizing the EVOC system to predict tumor response to targeted therapy when multiple targets are proposed.”

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Jul 11 2018

Hadassah Cancer Specialists Explore Link Between Colorectal Cancer and BRCA Mutations

Looking further into the link between colorectal cancer and BRCA 1 and 2 genetic mutations, researchers from the Hadassah Medical Center’s Sharett Institute of Oncology, together with colleagues from Chaim Sheba Medical Center, analyzed data from 32 patients with lower gastrointestinal cancers.

READ MORE ›
alt_text

Wednesday, Jul 11 2018

Improving Kidney Health of Premature Babies

Is the TV hit show Grey's Anatomy taking its inspiration from Hadassah Hospital? After all, cast members did visit Hadassah Ein Kerem in 2011. Dr. Oded Volovelsky, Head of Hadassah's new Pediatric Nephrology Unit says, only half-jokingly, that TV doc Meredith Grey might have read his research.

READ MORE ›
alt_text

Monday, Jul 9 2018

World Hepatitis Day: Hadassah’s Contribution to the Global Battle Against this Disease

“Hadassah Medical Organization's (HMO) greatest contribution to the global battle against Hepatitis are the vaccines that have been developed here,” said Prof. Daniel Shouval, as we mark World Hepatitis Day on July 28.

READ MORE ›
alt_text

Tuesday, Jul 3 2018

In a First, a Baby with a Severe Intestinal Defect Receives Medication That Allows Her to Eat Normally

Administering the lowest possible dosage of a medication never before used on a baby, Dr. Mordechai Slae, a senior pediatric gastroenterologist at Hadassah Medical Center, was able to ameliorate the condition of a 6-month-old baby born with a rare and severe defect in her large intestine.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More